Medicare Enrolled

Dr. Paul Brion, M.D.

Rheumatology · Vista, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
2023 W VISTA WAY, Vista, CA 92083
7607245800
In practice since 2005 (20 years)
NPI: 1295724326 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Brion from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Brion? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Brion

Dr. Paul Brion is a rheumatology specialist in Vista, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Brion performed 102,587 Medicare services across 1,360 unique beneficiaries.

Between the years covered by Open Payments, Dr. Brion received a total of $21,973 from 34 pharmaceutical and/or device companies across 168 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Brion is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 5% volume in CA $21,973 industry payments

Medicare Practice Summary

Medicare Utilization ↗
102,587
Medicare services
Top 5% in CA for rheumatology
1,360
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~5,129 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Certolizumab injection (Cimzia)
An injection of certolizumab pegol administered under the direct supervision of a physician.
75,601 $4 $14
Romosozumab injection (Evenity) for osteoporosis 13,020 $8 $11
Denosumab injection (Prolia/Xgeva) 9,480 $18 $49
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,166 $100 $190
Extended-release steroid injection (Zilretta)
An injection of triamcinolone acetonide using a preservative-free, extended-release microsphere formulation. The dosage is measured in milligrams.
1,152 $13 $26
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
799 $1 $8
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
352 $67 $189
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
200 $58 $200
New patient office visit, complex (60-74 min) 163 $179 $440
Orthovisc intra-articular injection
An injection of hyaluronan or its derivative into a joint space to provide lubrication and cushioning.
106 $98 $300
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
97 $73 $120
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
87 $117 $400
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
82 $57 $400
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
79 $12 $45
Flu vaccine, high-dose
High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe.
64 $69 $70
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
61 $34 $35
Joint fluid aspiration or injection, small joint
Removal of fluid from a small joint or injection of medication into a small joint.
30 $42 $140
Tendon or ligament injection
A procedure involving the injection of medication into a tendon or ligament.
19 $47 $120
Methylprednisolone acetate injection, 80 mg
An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication.
15 $9 $25
Joint fluid aspiration or injection, medium joint
Removal of fluid from a medium-sized joint or injection of medication into the joint space.
14 $49 $150
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.2% high complexity
98.3% medium
1.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$21,973
Total received (2018-2024)
Avg $3,139/year across 7 years
Top 16% in CA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
168
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$17,637 (80.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,886 (17.7%)
Scientific / Research
Research funding and grants
$385 (1.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$64 (0.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,435
2023
$728
2022
$1,010
2021
$136
2020
$24
2019
$18,264
2018
$376

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$181
Janssen Biotech, Inc.
$168
ABBVIE INC.
$143
Janssen Scientific Affairs, LLC
$138
GENZYME CORPORATION
$89
Aurinia Pharma U.S., Inc.
$86
Novartis Pharmaceuticals Corporation
$84
Mallinckrodt Hospital Products Inc.
$74
AstraZeneca Pharmaceuticals LP
$67
Amgen Inc.
$64
Boehringer Ingelheim Pharmaceuticals, Inc.
$62
DePuy Synthes Sales Inc.
$60
Organon Llc
$33
Zimmer Biomet Holdings, Inc.
$29
Fresenius Kabi USA, LLC
$28
ANI Pharmaceuticals, Inc.
$26
Radius Health, Inc.
$24
Kiniksa Pharmaceuticals International, plc
$23
Avanos Medical
$21
Alexion Pharmaceuticals, Inc.
$18
Lilly USA, LLC
$17
Top 3 companies account for 34.3% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$18,103
ABBVIE INC.
$528
Amgen Inc.
$324
UCB, Inc.
$295
Janssen Biotech, Inc.
$265
GlaxoSmithKline, LLC.
$252
Janssen Scientific Affairs, LLC
$238
Boehringer Ingelheim Pharmaceuticals, Inc.
$204
Lilly USA, LLC
$174
E.R. Squibb & Sons, L.L.C.
$167
AbbVie, Inc.
$167
AbbVie Inc.
$163
Aurinia Pharma U.S., Inc.
$126
Mallinckrodt Hospital Products Inc.
$112
Ironshore Pharmaceuticals Inc.
$98
AstraZeneca Pharmaceuticals LP
$91
GENZYME CORPORATION
$89
Flexion Therapeutics, Inc.
$87
DePuy Synthes Sales Inc.
$67
PFIZER INC.
$63
SANOFI PASTEUR INC.
$48
Radius Health, Inc.
$39
Organon Llc
$33
Zimmer Biomet Holdings, Inc.
$29
Fresenius Kabi USA, LLC
$28
ANI Pharmaceuticals, Inc.
$26
Horizon Therapeutics plc
$24
Kiniksa Pharmaceuticals International, plc
$23
Organon LLC
$23
Avanos Medical
$21
Orthogenrx Inc.
$21
Alexion Pharmaceuticals, Inc.
$18
SANOFI-AVENTIS U.S. LLC
$16
Exeltis, USA Inc.
$12
Top 3 companies account for 86.3% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AVSOLA · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · EVENITY · Enbrel · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FLUZONE HIGH-DOSE · Gel-One Cross-linked Hyaluronate · GenVisc 850 · Humira · IDACIO · ILARIS · INFLECTRA · Jornay PM 20mg capsules (Bottle of 100) · KEVZARA · KRYSTEXXA · LUPKYNIS · OFEV · ORENCIA · ORTHOVISC · PURIFIED CORTROPHIN GEL · RENFLEXIS · RINVOQ · Rinvoq · SAPHNELO · SIMPONI ARIA · SKYRIZI · SPEVIGO · STRENSIQ · Skyrizi · Sotyktu · TALTZ · TREMFYA · TRIVISC SODIUM HYALURONATE · Tavneos · Tremfya · Tymlos · XELJANZ · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (80%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware.

Looking for a rheumatology specialist in Vista?
Compare rheumatologists in the Vista area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
34
Per 100K population
1.0
County median income
$102,285
Nearest hospital
TRI-CITY MEDICAL CENTER
2.9 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Brion is a mixed practice specialist, with above-average Medicare volume (top 5% in CA), with speaking/promotional industry engagement in the top 16% of CA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Brion experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Brion performed 75,601 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Brion receive payments from pharmaceutical companies?
Yes. Dr. Brion received a total of $21,973 from 34 companies across 168 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Brion's costs compare to other rheumatologists in Vista?
Dr. Brion's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Brion) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →